Top Markets
Coin of the day
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.

BVXV
Clasificación en acciones #38547
BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company... BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company currently in its development stage. Its core mission involves the research, production, and market introduction of therapeutic products designed for the prevention and treatment of a range of infectious and other medical conditions. The company has established strategic licensing and collaboration agreements with prominent scientific institutions, notably the Max Planck Society and the University Medical Center Göttingen. These partnerships are geared towards the advancement and commercialization of nanosized antibodies (NanoAbs), including a specific candidate for COVID-19, and extending this technology to address various other disease indications. Founded in 2003, BiondVax maintains its corporate headquarters in Jerusalem, Israel.
Precio por acción
$0.8
Última sincronización: 2023-10-03
Capitalización bursátil
$922.40K
Cambio (1 día)
-5.88%
Cambio (1 año)
0.00%
País
IL
Comercio BiondVax Pharmaceuticals Ltd. (BVXV)

Categoría

Historial del precio de la acción de BiondVax Pharmaceuticals Ltd. (BVXV)
Precio más alto de cierre: $0.83 el 2023-10-01

Precio más bajo de cierre: $44.88 el 2015-05-01
Historial del precio de la acción de BiondVax Pharmaceuticals Ltd. desde 2015 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 -87.88%
2022 -64.25%
2021 -42.77%
2020 -52.99%
2019 40.72%
2018 -2.41%
2017 42.21%
2016 -4.29%
2015 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$505.45 29.50%
US
$847.28 29.87%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE